Japanese multinational NEC has bought the Norway-based bioinformatics firm OncoImmunity, which develops proprietary machine learning software to support cancer R&D.
GlaxoSmithKline has confirmed that it has hired Jonathan Symonds as chairman, confirming press speculation that the former Novartis and AstraZeneca finance chief was in the frame to replace
